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ABSTRACT 
Background: International electrocardiographic (ECG) recommendations regard anterior T-
wave-inversion (ATWI) in athletes <16 years to be normal.  
Design: Identify the prevalence, distribution, and determinants of TWI by ethnicity, chronological 
and biological age within paediatric athletes. Secondly, establish diagnostic accuracy of 
international ECG recommendations against refinement within athletes who present ECG variants 
isolated to ATWI (V1-V4) using receiver operator curve (ROC) analysis. Clinical context was 
calculated using Bayesian analysis. 
Methods: 418 Arab and 314 black male athletes (11-18 years) were evaluated by ECG, 
echocardiogram and biological age (via radiological x-ray) assessment.   
Results: 116 (15.8%) athletes presented ATWI (V1-V4), of which 96 (82.8%) were ECG variants 
isolated to ATWI.  91 (12.4%) athletes presented ATWI confined to V1-V3, with prevalence 
predicted by black ethnicity (odds ratio (OR) 2.2; 95% CI 1.3-3.5) and biological age <16 years 
(OR 2.0; 95% CI 1.2-3.3). Of the 96 with ATWI (V1-V4) observed in the absence of other ECG 
findings considered to be abnormal as per international recommendations for ECG interpretation 
in athletes, diagnostic accuracy was ‘fail’ (0.47 95% CI 0.00-1.00) for international 
recommendations and ‘excellent’ (0.97 95% CI 0.92-1.00), when governed by biological age <16 
years, providing a positive (+LR) and negative (-LR) likelihood ratio of 15.8 (95% CI 1.8-28.1) 
and 0.0 (95% CI 0.0-0.8), respectively.   
Conclusion: Interpretation of ECG variants isolated to ATWI (V1-V4) using international 
recommendations (chronological age <16 years), warrants caution, but governance by biological 
age yielded an ‘excellent’ diagnostic accuracy.  In clinical context, the ‘chance’ of detecting 
cardiac pathology within a paediatric male athlete presenting ATWI in the absence of other ECG 
findings considered to be abnormal as per international recommendations for ECG interpretation 
in athletes (+LR=15.8), was 14.4%, whereas a negative ECG (-LR=0.0) was 0%.  
Key words: Athlete’s Heart, Paediatric, Maturation, Electrocardiogram, T-Wave-Inversion, 
Sudden Cardiac Death.  
INTRODUCTION 
T wave inversion (TWI) may represent the only sign of cardiac pathology predisposing to sudden 
cardiac death/arrest (SCD/A) without phenotypic manifestation on secondary investigation1. 
Whilst lateral, inferolateral and inferior TWI are universally recognised as abnormal, international 
recommendations for electrocardiographic (ECG) interpretation in athletes regard anterior TWI 
(ATWI) in V1–V4 when preceded by J termination (Jt) and/or ST-segment elevation in black 
athletes, in V1–V3 when chronological aged <16 years, and biphasic in V3 only, to be normal and 
does not require further evaluation in the absence of other clinical or ECG features suggestive of 
cardiomyopathy2.   
 
Prior work within white athletes recognizes ATWI extending beyond V2 to be rare in those aged 
≥16 years (0.1%)3 and beyond V3 with complete pubertal development (1.6%)4. Subsequently, 16 
years marks the cut off (TWI in V1–V3) for international ECG interpretation recommendations. 
Additional work within white and black adult athletes demonstrates that detailed assessment of Jt 
and/or ST-segment amplitude preceding ATWI can accurately discriminate physiological 
adaptation from cardiomyopathy, independent of ethnicity5. Yet, the appropriateness of such 
assessments in Arab and black paediatric athletes is unknown. Unlike chronological age, 
maturation status is not linear; varying in extreme cases by six years between two 9-year-old 
males6. Previous investigators have considered maturational status when interpreting an ECG4 but 
used Tanner staging assessment7, now regarded as inappropriate due to child protection concerns. 
Furthermore, self-assessment yields poor validity (27%)8. Alternatively, skeletal age (biological 
age) assessment via radiological hand-wrist X-ray examination is recognised by the International 
Olympic Committee as the ‘gold standard’ estimate of maturity status9. To interpret presentation 
of ATWI in clinical context, especially when there is no ‘gold standard’ test to identify cardiac 
pathology, Bayesian analysis allows for the quantification of ‘chance’ of pathology as per 
examination methodology (in this case, ECG interpretation), based upon pre- and post-test odds10. 
 
Accordingly, our primary aim was to identify the prevalence, distribution, and determinants of 
TWI by ethnicity, chronological and biological age within a large cohort of Arab and black 
paediatric athletes. Secondarily, we aimed to establish diagnostic accuracy of international ECG 
recommendations against refinement in paediatric athletes who present ECG variants isolated to 
ATWI (V1-V4,) by receiver operator curve (ROC) analysis. Clinical context was calculated using 
Bayesian analysis. 
 
METHODS 
Ethical Approval 
Ethical approval was provided by Anti-Doping Laboratory Qatar (IRB #E2013000003 and 
#E20140000012), with all parents/guardians providing informed consent.  
 
Participants 
Between 2009-2017, 418 Arab and 314 black male paediatric athletes registered with the Qatar 
Olympic Committee [exercising ≥6 hours/week, aged 11-18 years.] presented at our institution for 
ECG screening. Ethnicity was self-determined by the athlete (or guardian) in accordance to 
definitions offset by the UK government’s statistical service11.  Based on 2-year chronological age 
categories participants’ demographic distribution is described in Table 1. Whilst we acknowledge 
ECG interpretation criteria were developed for athletes aged 12-35 years2, a minority of athletes 
<12 years presented at the request of the Qatar Olympic Committee. 
 
Preliminary Investigations  
Health questionnaire and physical examination  
Athletes completed a health questionnaire (with primary guardians) regarding family history of 
cardiovascular disease and personal symptoms, together with anthropometric (height and body 
mass; body surface area [BSA]12) and left brachial artery blood pressure assessment in 
collaboration with an Arabic, French, and/or English-speaking nurse. Precordial auscultation in 
supine and standing positions and assessment for underlying congenital or syndromal disorders 
were undertaken by a sports medicine physician.  
 
Resting 12-lead ECG 
ECG was recorded with standard 12-lead positions using a GE Mac 5500 (New York, USA). All 
726 ECGs were retrospectively interpreted by GMC applying international recommendations2, 
whilst blinded to pathology. ECG variants isolated to ATWI (V1-V4), were secondarily interpreted 
by: Jt and/or ST-segment elevation irrespective of ethnicity and biological age <16 years when 
confined to V1-V3.  
 
The amplitude of the J termination (Jt)13 was measured at the end of the QRS complex (the onset 
of the ST-segment) with reference to the onset of the QRS complex and was considered elevated 
if Jt ≥0.1mV or depressed if Jt ≤-0.1 mV (Figure 1). The ST-segment was considered elevated if 
the amplitude of the ST-segment 100ms after Jt (interval M) were greater than the amplitude at Jt, 
depressed if below and isoelectric if in line with the Jt.  
 
Echocardiography  
2D transthoracic echocardiographic examination was performed using IE33 (Philips, USA) and 
Artida (Toshiba Medical Systems, Japan) ultrasound systems. Standard views were obtained and 
analysed for left and right ventricular wall thickness and cavity dimensions as well as the 
identification of the origins of the left and right coronary arteries in accordance with current 
guidelines14.  
 
Chronological and Biological Age Assessment 
Chronological age was calculated as the difference between date of birth as per passport and date 
of examination. Radiological hand-wrist imaging using a Digital Diagnost (Philips, USA) of the 
left hand-wrist allowed biological age estimation by the Fels method15, by a single examiner with 
previously demonstrated intra-class correlation coefficient of 0.9986. Radiation exposure is 
considered almost negligible (0.00017 millisievert); corresponding to 1 hour of background 
radiation from major cities in the UK16,17. 
 
Further Investigations 
Athletes presenting with an abnormal health questionnaire, physical examination, ECG or 
echocardiographic examination suggestive of underlying cardiovascular pathology were invited 
for further evaluation. Subsequent examinations may have included 24h-ECG or ambulatory blood 
pressure monitoring, maximal cardiopulmonary exercise testing, electrophysiology 
study, computerized tomography and cardiac magnetic resonance imaging. Diagnosis of disease 
was established and managed in accordance to guidelines18–24. 
 
Statistical Analysis  
Data were expressed as mean (±SD) or percentages as appropriate and analysed with SPSS 
software (Version 21.0, Chicago, IL). Continuous variables were tested for normality using the 
Shapiro-Wilk test. Comparisons between groups were performed using a student t-test for 
continuous variables by ethnicity (Arab vs. black), and χ2 test or Fisher’s exact tests for categorical 
variables by ethnicity (Arab vs. black), and biological age (<16 vs. ≥16 years). Z tests, adjusted 
for Bonferroni (P≤0.05), allowed for multiple comparisons to explain the effect of biological age 
(10-12 years. vs. 13-14 years. vs. 15-16 years. vs. 17-18 years.), within ethnicity, upon the 
prevalence of TWI by territory. Univariate and multivariate binomial logistic regression was used 
to determine which factors (black ethnicity, chronological, or biological age <16 years) were 
significantly associated with the presence of TWI by territory; calculated from those with no 
identified cardiac pathology. International recommendations2 guided selection of chronological 
and biological age of <16 years. 
 
ROC curve analysis was used to describe the sensitivity and specificity of ECG interpretation 
criteria to identify cardiac pathology that may predispose to SCA/D25. Area under the curve 
represented diagnostic accuracy in differentiating athletes with cardiac pathology; interpreted as 
excellent (>0.90), good (0.80-0.90), fair (0.70-0.80), poor (0.60-0.70), or fail (<0.60)26. Positive 
(+LR) and negative likelihood ratios (-LR) were calculated from the specificity and sensitivity 
values of ECG interpretation criteria, to allow estimation of ‘chance’ of cardiac pathology, after 
application of ECG interpretation criteria. Specifically, base prevalence rate was determined from 
the pre-test odds, and the +LR and –LR was used to compute the post-test odds10.   
 
RESULTS 
Demographics  
 Arab athletes descended from West-Asia (85.8%), Africa (14.0%), and North America (0.2%). 
Black athletes descended from Africa (66.2%), West-Asia (30.6%), and Central America (3.2%). 
Athletes participated in 26 different sports, with football (60.5%) dominating. Whilst 
chronological age (14.6 ± 2.0 vs. 14.2 ± 1.5, years, p<0.01), and BSA (1.63 ± 0.22 vs. 1.59 ± 0.29, 
m2, p<0.05) were significantly greater in Arab than black athletes, biological age (16.6 ± 1.7 vs. 
15.7 ± 2.1, years, p<0.001) was significantly greater in black than Arab athletes (Table 1).  
 
Abnormal ECG findings 
Abnormal ECGs that required further evaluation were more frequent in black than Arab athletes 
(12.1% vs. 4.3%, P<0.001) (Figure 2).  Specifically, 5.1% and 2.2% of black and Arab athletes, 
presented an abnormal TWI according to international recommendations, with a diagnostic yield 
for cardiac pathology of 3.0% and 3.4%, respectively. 
 
Prevalence of ATWI (V1-V4)  
Overall, 116 (15.8%) paediatric athletes presented ATWI (V1-V4), of which 96 (82.8%) were 
observed in the absence of other ECG findings considered to be abnormal as per international 
recommendations for ECG interpretation in athletes. Prevalence was more common in athletes 
biologically aged <16 than ≥16 years (18.8% vs. 13.6%, p<0.05), and in black than Arab athletes 
(23.2% vs. 10.3%, p<0.0001).  
 
Distribution of ATWI 
Ninety-one (12.4%) athletes presented with ATWI confined to V1-V3, constituting 79.3% of all 
ATWI cases (Figure 3). A further 25 (3.4%) athletes exhibited ATWI beyond V3, with prevalence 
similar in athletes biologically aged ≥16 and <16 years, but more common in black than Arab 
athletes (7.0% vs. 0.7%, p<0.001). Prevalence was similar across biological age groups for black 
athletes (10-12 years. [7.1%], 13-14 years. [4.0%], 15-16 years. [5.6%] and 17-18 years. [8.4%]) 
compared to zero cases in Arab athletes biologically aged >14 years (Table 2).  
 
JT elevation and ST-segment morphology preceding ATWI confined to V1-V3  
ATWI confined to V1-V3 was preceded by Jt elevation in 37.4%. Jt elevation was more common 
in athletes biologically aged ≥16 than <16 years (52.5% vs. 25.5%, p<0.01) and in black than Arab 
athletes (56.9% vs. 12.5%, p<0.001).  
 
ATWI in V1-V3 was preceded by ST morphology that was isoelectric in 62.6%, and ascending 
convex in 37.4% (Figure 4). Isoelectric ST-segment morphology was more frequent in athletes 
biologically aged <16 than ≥16 years (74.5% vs. 47.5%, p<0.01).  
 
JT elevation and ST-segment morphology preceding ATWI extending beyond V3 
ATWI extending beyond V3 was preceded by Jt elevation in 52.0%. Whilst prevalence did not 
differ by biological age, this observation was confined to black athletes (59.1%). ATWI extending 
beyond V3 was frequently preceded by ST morphology that was isoelectric in 48.0%, and 
ascending convex in 52.0% (Figure 4). No healthy athlete with ATWI demonstrated a depressed 
Jt/ST-segment. 
 
Lateral, Inferolateral and Inferior TWI 
Fifteen (2.0%) athletes presented lateral TWI with prevalence unaffected by biological age, but 
more common in black than Arab athletes (3.5% vs. 1.0%, p<0.02); prevalence was sustained 
across all biological age groups in black athletes. Four (0.5%) and eight (1.1%) athletes presented 
with inferior and inferolateral TWI, respectively, whilst neither form of repolarization 
demonstrated an association with ethnicity, chronological or biological age. 
 
Determinants of TWI  
Of the 726 athletes with no detected cardiac pathology, univariate predictors of ATWI confined to 
V1-V3 were black ethnicity (odds ratio (OR) 1.9; 95% CI 1.2-3.0), chronological age <16 (OR 2.6; 
95% CI 1.3-5.4), and biological age <16 years (OR 1.9; 95% CI 1.2-3.0). On multivariable analysis 
only black ethnicity (OR 2.2; 95% CI 1.3-3.5) and biological age <16 years (OR 2.0; 95% CI 1.2-
3.3) remained. Black ethnicity was the only univariate predictor of ATWI extending beyond V3 
(OR 8.9; 95% CI 2.6-30.4), and lateral TWI (OR 4.0; 95% CI 1.1-15.2). 
 
Diagnostic yield and accuracy of TWI interpretation 
Anterior TWI 
Four of 116 (3.4%) with ATWI (V1-V4) and 1 of 96 (1.0%) with ATWI (V1-V4) observed in the 
absence of other ECG findings considered to be abnormal as per international recommendations 
for ECG interpretation in athletes, were diagnosed with pathology (Table 3). Of these 96, 
diagnostic accuracy was ‘fail’ [0.47 95% CI 0.00-1.00] for international recommendations, ‘fail’ 
[0.48 95% CI 0.00-1.00] for international recommendations when governed by Jt and/or ST-
segment elevation irrespective of ethnicity, and ‘excellent’ [0.97 95% CI 0.92-1.00] for 
international recommendations when governed by biological not chronological age <16 years 
(Figure 5) 
 
Lateral, Inferolateral and Inferior TWI 
Three of 15 (20.0%) athletes with lateral TWI were diagnosed with pathology. Of these fifteen, 8 
presented ECG abnormalities confined to lateral TWI, with pathology diagnosed in the only Arab 
athlete. 1 of 4 (20%) and 1 of 8 (12.5%) athletes with inferior and inferolateral TWI, respectively, 
were diagnosed with pathology. No pathology was diagnosed in athletes with ECG abnormalities 
confined to inferior (n=3) or inferolateral (n=2) TWI. 
 
Diagnostic accuracy of international recommendations in all athletes 
Diagnostic accuracy of cardiac pathology was ‘fair’ (0.79 95% CI 0.57-1.00) for international 
recommendations (specifically, a ‘poor’ [0.65 95% CI 0.28-1.00] diagnostic accuracy for Arab and 
an ‘excellent’ [0.94 95% CI 0.90-99] diagnostic accuracy for Black athletes),  and ‘good’ (0.88 
95% CI 0.71-1.00) when governed by biological age <16 years (specifically, a ‘good’ [0.81 95% 
CI 0.49-1.00] diagnostic accuracy for Arab and an ‘excellent’ [0.94 95% CI 0.90-99] diagnostic 
accuracy for Black athletes) (Figure 5).  
 
Clinical implications when governing international recommendations by biological age 
Overall, international recommendations provided a +ve and -ve LR of 9.3 (95% CI 4.0-14.5) and 
0.4 (95% CI 0.1-0.8), respectively. When governed by biological age, +ve and -ve LR were 11.4 
(95% CI 5.7-16.0) and 0.2 (95% CI 0.03-0.6), respectively. When split by ethnicity, +ve and -ve 
LR were 15.4 (95% CI 4.5-29.3) and 0.3 (95% CI 0.06-0.8) in Arab and 8.9 (95% CI 3.0-11.2) and 
0.0 (95% CI 0.0-0.6) in Black athletes, respectively. 
 
Of the 96 with ECG variants isolated to ATWI (V1-V4), international recommendations provided 
a +ve and -ve LR of 0.0 (95% CI 0.0-22.8) and 1.1 (95% CI 0.1-1.0), respectively. If governing 
by biological age in this cohort, +ve and -ve LR were 15.8 (95% CI 1.8-28.1) and 0.0 (95% CI 
0.0-0.8), respectively. 
 
DISCUSSION 
Differentiating benign from pathological T-wave inversion represents one of sports cardiology 
greatest conundrums. This study of 418 Arab and 314 black male paediatric athletes demonstrated 
that: ATWI confined to V1-V3 was prevalent among 12.1% of athletes, with prevalence predicted 
by black ethnicity and biological age, but not chronological age <16 years; whilst ATWI extending 
beyond V3 was rare (3.4%), its prevalence was predicted by black ethnicity, and sustained across 
all biological age groups for this ethnicity; and finally diagnostic accuracy of international 
recommendations for cardiac pathology in athletes presenting ECG variants isolated to ATWI (V1-
V4), improved from ‘fail’ to ‘excellent’ with biological not chronological age governance. In 
clinical context, the ‘chance’ of detecting cardiac pathology within a paediatric male athlete 
presenting ECG variants confined to ATWI (V1-V4) is approximately 1%. A positive ECG 
(+LR=15.8) using biological age governance to international recommendations means the same 
athlete now has a 14.4% ‘chance’ of pathology, whereas a negative ECG (-LR=0.0) has a 0% 
‘chance’.  
 
Prevalence and Distribution of ATWI  
In a recent systematic review with meta-analysis of over 6000 white and 500 black male paediatric 
athletes27, a relatively high prevalence of ATWI was observed (4.2% vs 12.2%, respectively). We 
observed AWTI confined to V1-V3 in 16.2% and 9.6% of black and Arab paediatric athletes, 
respectively. Although this may represent a ‘juvenile’ ECG when aged <16 years2; of the 11 
articles3,4,28–36 whom previously detailed its prevalence and significance, only 43,4,32,35 documented 
maturity status, of which 34,32,35 relied on Tanner Staging. For the first time we considered 
biological age, recognised by the International Olympic Committee as the ‘gold standard’ estimate 
of maturity9. Biological age <16 years and black ethnicity, not chronological age <16 years 
predicted ATWI confined to V1-V3. In extension to Sheikh et al.
36 who observed ATWI extending 
beyond V2 in black athletes (14-18 years) in 74% of cases, we demonstrated ATWI extending 
beyond V3 within black athletes (11-18 years) in 30.0%. Furthermore, prevalence was sustained 
irrespective of biological age group for this ethnicity, suggesting that this may represent a benign, 
ethnic manifestation of the athlete’s heart, irrespective of biological age.   
 
Potential markers of pathology in paediatric athletes with ATWI 
The prevalence of ATWI confined to V1-V3 is increased in male paediatric athletes of younger 
biological age, with presentation in 15.2% Arab and 27.1% black athletes biologically aged <16 
years. Thus creating considerable overlap in the differential diagnosis of myocarditis, 
arrhythmogenic right ventricular cardiomyopathy and hypertrophic cardiomyopathy. Accordingly, 
international recommendations for ECG interpretation in athletes2 recognize the ‘juvenile ECG 
pattern’ (TWI in V1-V3, chronological aged <16 years) to be normal. This assumes, however, an 
immature heart unlikely to have undergone complete formation of adult ventricular mass, with 
TWI in V1–V3, attributable to right ventricular dominance. In reality, whilst chronological age is 
a linear factor, growth and maturation are not6. Subsequently, international recommendations 
failed to detect one case of myocarditis, with TWI in V1-V3 in an Arab athlete (chronological age 
14 years), yielding a ‘failed’ diagnostic accuracy for ECG variants isolated to ATWI (V1-V4). In 
contrast to observations of adult athletes by Calore et al.5, assessment of the preceding Jt and/or 
ST-segment amplitude irrespective of ethnicity, yielded a ‘failed’ diagnostic accuracy. Further, 
ATWI confined to V1-V3, where preceded by a Jt in line with the onset of the QRS and/or ST-
segment that were isoelectric in 62.6%, of which 66.7% were biologically aged <16 years. Finally, 
international recommendations governed by biological not chronological age <16 years, yielded 
an ‘excellent’ diagnostic accuracy. We believe that when presented with an asymptomatic 
paediatric athlete with ECG variants isolated to TWI in V1-V3, biological age assessment presents 
an opportunity to reassure the concerned parent/guardian and athlete. TWI in V1-V3 in athletes 
biologically aged <16 years is likely a ‘juvenile ECG pattern’ not warranting further investigation, 
but when biologically aged >16 years, further investigation may be warranted.  
 
Lateral, Inferolateral and Inferior TWI 
In this study of 732 athletes, TWI was detected in lateral leads in 2.0%, inferior leads in 1.1% and, 
inferolateral leads in 0.5%, with presentation of lateral TWI predicted by black ethnicity. These 
repolarization patterns are considered abnormal, as confirmed by a recent study37 which observed 
that in black athletes with cardiomyopathy or a genetic mutation of cardiomyopathy, all presented 
lateral TWI. Whilst ECG abnormalities confined to lateral TWI yielded cardiac pathology in the 
only Arab athlete, pathology was not detected in any black athlete. Whether this represents the 
first sign of cardiac pathology, with phenotypic manifestations appearing on secondary 
investigation in later life or an ethnic manifestation of the athlete’s heart remains to be determined. 
It is universally recognized, however, that these ECG patterns require serial long-term follow-up.   
 
Clinical implications when governing international recommendations by biological age  
If presented with a paediatric athlete for ECG screening, diagnostic accuracy of international 
recommendations improved from ‘fair’ to ‘good’, when governed by biological age <16 years. 
With consideration to Bayesian analysis10, our overall baseline ‘chance’ of detecting cardiac 
pathology was 0.8%. A positive ECG (+LR=11.4), means that the same athlete now has an 8.6% 
‘chance’ of cardiac pathology, whereas an athlete with a negative ECG (-LR=0.2), would have a 
0.2% ‘chance’. We therefore provide further evidence that ECG screening is an effective strategy 
for detecting cardiac pathology that may predispose to SCD/A in the paediatric athlete38,39. Whilst 
international recommendations represent the current ‘gold-standard’ for ECG interpretation in the 
paediatric athlete40, their governance by biological age, irrespective of cardiac pathology 
prevalence, increases the likelihood of correctly triggering further evaluation to identify cardiac 
pathology, whilst reducing the likelihood of incorrectly clearing an athlete to play with potential 
sinister consequences.  
 
Limitations 
Although no cardiac pathology was detected in paediatric athletes presenting ECG variants 
isolated to ATWI in V1-V3 with a biological age <16 years, we cannot exclude the development 
of cardiac pathology in later years due to the cross-sectional design. Accordingly, we consider 
observation to provide only reassurance that this likely represents a ‘juvenile ECG pattern’, 
requiring annual follow-up until resolution. Tanner staging assessment was not conducted in 
conjunction to biological age assessment due to numerous child protection concerns in addition to 
a lack of validity for this estimation of maturity when conducted by self-assessment. Finally, our 
population were exclusively Arab and black male athletes, limiting application of our data to other 
ethnicities and the female paediatric athlete. 
 
Conclusion 
Interpretation of ECG variants isolated to ATWI in V1-V4 using international recommendations 
based on chronological age <16 years, warrants caution, but when governed by biological age <16 
years yielded an ‘excellent’ diagnostic accuracy. Interpretation of the paediatric athletes ECG 
using biological age governance to international recommendations provides the best likelihood of 
triggering further evaluation in the attempt to detect cardiac pathology. 
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Figure Legends 
 
Figure 1. Measurement of J termination (Jt) elevation and classification of ST-segment 
morphology, preceding anterior T wave-inversion. (A) The horizontal dashed line through the 
onset of the QRS complex, acted as a reference for the measurement of J termination (Jt). The 
vertical dashed line defines the M interval (100ms). ST-segment morphologies are shown as the 
following: (B) ascending convex, and (C) isoelectric. 
Figure 2. International recommendations for ECG interpretation in Arab and Black paediatric 
athletes. 
Figure 3. Figure 2. International recommendations for ECG interpretation in Arab and Black 
paediatric athletes.  
Key: data are presented as n (%). AV, atrioventricular; CRBBB, complete right bundle branch 
block; CLBBB, Complete left bundle branch block; IRBBB, Incomplete right bundle branch 
block; IVCD, intraventricular conduction delay; LAD, left axis deviation; LAE, left atrial 
enlargement; RAD, right axis deviation; RAE, right atrial enlargement; PVCs, premature 
ventricular contractions.  
*p≤0.05, significantly more prevalent in black than Arab athletes’ ** p≤0.001, significantly more 
prevalent in black than Arab athletes; † p≤0.001, significantly more prevalent in Arab than black 
athletes. 
Figure 4. Bar graph shows ST-Segment morphology type preceding anterior T-wave inversion 
confined to V1-V3 by (A) ethnicity, and (B) biological age (BA) and anterior T-wave inversion 
extending beyond V3 by (C) ethnicity, and (D) biological age. *P <0.05, significant effect of group. 
Figure 5. Receiver-operating curves according to ECG interpretation criteria to detect cardiac 
pathology predisposing to sudden cardiac death/arrest only. Area under curve (AUC) represents 
test accuracy in differentiating athletes with cardiac pathology predisposing to an increased risk of 
sudden cardiac death/arrest.  (A) Athletes presenting with ECG variants isolated to T-wave 
inversion V1-V4 by (1) international recommendations, (2) when governed by Jt and/or ST-
segment elevation irrespective of ethnicity and, (3) when governed by biological age (BA) < 16 
years with T-wave inversion confined to V1-V3. (B) All athletes by (1) international 
recommendations and (2) when governed by biological age < 16 years with anterior T-wave 
inversion confined to V1-V3 
TABLES 
Table 1. Anthropometric data of paediatric athletes 
Chronological 
age group 
(years) 
Group N % Biological age Height (cm) Body mass (kg) BSA (m2) 
11-12 Total 147 20.1 13.4 ± 1.4 151.6 ± 8.8 44.3 ± 10.7 1.36 ± 0.19 
 Arab 111  13.2 ± 1.3 150.1 ± 7.8 43.2 ± 9.0 1.34 ± 0.16 
 Black 36  13.8 ± 1.6* 156.1 ± 10.1** 47.4 ± 14.4 1.42 ± 0.25* 
13-14 Total 355 48.5 16.2 ± 1.6 166.3 ± 9.5 128.8 ± 56.1 1.60 ± 0.21 
 Arab 148  15.5 ± 1.5 163.3 ± 10.2 54.6 ± 14.5 1.56 ± 0.24 
 Black 207  16.8 ± 1.4*** 168.7 ± 8.3*** 57.4 ± 10.4 1.63 ± 0.18** 
15-16 Total 135 18.4 17.3 ± 1.1 172.3 ± 8.6 64.8 ± 18.6 1.75 ± 0.28 
 Arab 92  17.4 ± 0.9 173.2 ± 8.6 66.9 ± 20.0 1.78 ± 0.29 
 Black 43  17.2 ± 1.3 170.1 ± 8.1 60.0 ± 13.7 1.67 ± 0.22 
17-18 Total 95 13.0 17.8 ± 0.5 174.3 ± 6.8 70.0 ± 10.4 1.8 ± 0.2 
 Arab 67  17.9 ± 0.5 174.5 ± 7.1 66.7 ± 9.5 1.79 ± 0.15 
 Black 28  17.8 ± 0.5 173.9 ± 6.2 67.7 ± 12.3 1.80 ± 0.18 
Values are mean ± standard deviation; BSA, Body surface area. 
*p≤0.05, significantly more prevalent or greater in black than Arab athletes 
** p≤0.01, significantly more prevalent or greater in black than Arab athletes 
*** p≤0.001, significantly more prevalent or greater in black than Arab athletes 
Table 2. Athletes with TWI by biological age group within ethnicity and by territory 
 Arab Black Arab Black Arab Black Arab Black 
 10-12 years 13-14 years 15-16 years 17-18 years 
 n=52 n=14 n=122 n=50 n=66 n=72 n=178 n=178 
Anterior 
V1-V3 7 (13.5) 2 (14.3) 20 (16.4)
† 13 (26.0) 3 (4.5) 10 (13.9) 10 (5.6) 26 (14.6)* 
Beyond V3 2 (3.8) 1 (7.1) 1 (0.8) 2 (4.0) 0 (0) 4 (5.6) 0 (0) 15 (8.4)* 
Lateral 2 (3.8) 0 (0) 0 (0) 1 (2.0) 2 (3.0) 4 (5.6) 0 (0) 6 (3.4)* 
Inferolateral 1 (1.9) 0 (0) 0 (0) 0 (0) 1 (1.5) 2 (2.8) 0 (0) 1 (0.6) 
Inferior 1 (1.9) 0 (0) 0 (0) 0 (0) 3 (4.5) 1 (1.4) 1 (0.6) 1 (0.6) 
Data are presented as number (%) for each column.  
Lateral, leads I and AVL, V5 and/or V6 (only one lead of TWI required in V5 or V6); Inferolateral, leads II and aVF, V5-V6, I and 
AVL; Inferior, leads II and aVF. 
*p≤0.05, significantly more prevalent in black than Arab athletes of the same biological age group 
†p≤0.05, significantly more prevalent than in Arab athletes biologically aged 17-18 years. 
 Table 3. Clinical characteristics of athletes diagnosed with cardiac pathology that may predispose to SCD/A.  
Condition Chronological 
Age 
Biological 
Age 
Ethnicity International 
 
International  
governed by  
Biological  
Age 
TWI Other 
Aneurysm with dilated 
ascending aorta 
 
12 11.6 Arab - - - - 
HCM 
 
 
 
13 18 Black + + AVL, V2-V5 Q waves 
II, III, AVF, 
V5, V6 
LVNC 
 
 
13 17 Black + + II, III, AVF, 
V1-V6 
Q waves 
II, III, AVF, 
V4 -V6 
 Myocarditis, with 
anterolateral, lateral and 
inferolateral mid-wall fibrosis 
at basal level. 
 
14 17.7 Arab - + V1-V3 - 
Myocarditis, with 
anterolateral, lateral and 
inferolateral mid-wall fibrosis 
at basal and mid ventricular 
level 
 
13 15.4 Arab + + AVL, V1, 
V4-V5 
- 
WPW ECG pattern 13 18 Black + + AVL,V1-V4 Short PR 
interval 
Delta Wave 
Wide QRS 
Hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; MVP; Mitral Valve Prolapse; MR; mitral regurgitation; SCA/D, 
sudden cardiac arrest/death; TWI, T-wave inversion; WPW; Wolf-Parkinson-White syndrome. 
FIGURES 
Figure 1. Measurement of J termination (Jt) elevation and classification of ST-segment morphology, preceding anterior T wave-
inversion. (A) The horizontal dashed line through the onset of the QRS complex, acted as a reference for the measurement of J 
termination (Jt). The vertical dashed line defines the M interval (100ms). ST-segment morphologies are shown as the following: (B) 
ascending convex, and (C) isoelectric.  
 
  
Figure 2. International recommendations for ECG interpretation in Arab and Black paediatric athletes.  
Key: data are presented as n (%). AV, atrioventricular; CRBBB, complete right bundle branch block; CLBBB, Complete left bundle 
branch block; IRBBB, Incomplete right bundle branch block; IVCD, intraventricular conduction delay; LAD, left axis deviation; LAE, 
left atrial enlargement; RAD, right axis deviation; RAE, right atrial enlargement; PVCs, premature ventricular contractions.  
*p≤0.05, significantly more prevalent in black than Arab athletes’ ** p≤0.001, significantly more prevalent in black than Arab athletes; 
† p≤0.05, significantly more prevalent in Arab than black athletes; †† p≤0.001, significantly more prevalent in Arab than black athletes. 
 
  
  
Figure 3. Prevalence and distribution of T-wave inversion in both Arab and black. Numbers in brackets express percentages (%) of 
each cohort.  
 
 Figure 4. Bar graph shows ST-Segment morphology type preceding anterior T-wave inversion confined to V1-V3 by (A) ethnicity, and 
(B) biological age (BA) and anterior T-wave inversion extending beyond V3 by (C) ethnicity, and (D) biological age. *P <0.05, 
significant effect of group
 
Figure 5. Receiver-operating curves according to ECG interpretation criteria to detect cardiac 
pathology predisposing to sudden cardiac death/arrest only. Area under curve (AUC) represents 
test accuracy in differentiating athletes with cardiac pathology predisposing to an increased risk of 
sudden cardiac death/arrest.  (A) Athletes presenting with ECG variants isolated to T-wave 
inversion V1-V4 by (1) international recommendations, (2) when governed by Jt and/or ST-
segment elevation irrespective of ethnicity and, (3) when governed by biological age (BA) < 16 
years. (B) All athletes by (1) international recommendations and (2) when governed by biological 
age < 16 years with anterior T-wave inversion confined to V1-V3 
